Fructus ligustri lucidi ethanol extract improves bone mineral density and properties through modulating calcium absorption-related gene expression in kidney and duodenum of growing rats

Calcified Tissue International

Volumn 94, Issue 4, 2014, Pages 433-441

  Feng, Xin ^a   Lyu, Ying ^a   Wu, Zhenghao ^a   Fang, Yuehui ^a   Xu, Hao ^a   Zhao, Pengling ^b   Xu, Yajun ^a,c   Feng, Haotian ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety   (China)

Author keywords

1 Hydroxylase; CaBP 9k; Calcium absorption; Fructus ligustri lucidi; TRPV6; VDR

Indexed keywords

ALCOHOL; CALBINDIN; CALCIUM; CALCIUM TRANSPORTER CALBINDIN D9K; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; LIGUSTRUM LUCIDUM EXTRACT; OSTEOCALCIN; OXYGENASE; PARATHYROID HORMONE; PHOSPHORUS; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 6; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; HERBACEOUS AGENT; PLANT EXTRACT; S100 CALCIUM BINDING PROTEIN G; STEROID MONOOXYGENASE; VANILLOID RECEPTOR; VITAMIN D; VITAMIN D 1-ALPHA HYDROXYLASE;

ANIMAL EXPERIMENT; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE GROWTH; BONE LENGTH; BONE MASS; BONE TURNOVER; CALCIUM ABSORPTION; CALCIUM BALANCE; CALCIUM BLOOD LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG MECHANISM; DUODENUM; FEMUR; FOOD INTAKE; FRUIT; GENE EXPRESSION; KIDNEY; MALE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRABECULAR BONE; UPREGULATION; WEIGHT GAIN; ANIMAL; BONE; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; LIGUSTRUM; METABOLISM; OSTEOPOROSIS; SPRAGUE DAWLEY RAT;

ANIMALS; BONE AND BONES; BONE DENSITY; CALCIUM; DRUGS, CHINESE HERBAL; DUODENUM; ETHANOL; FEMUR; GENE EXPRESSION REGULATION; KIDNEY; LIGUSTRUM; MALE; OSTEOPOROSIS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITRIOL; S100 CALCIUM BINDING PROTEIN G; STEROID HYDROXYLASES; TRPV CATION CHANNELS; UP-REGULATION; VITAMIN D;

EID: 84896482201     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-013-9825-4     Document Type: Article

References (43)

1. Cummings SR, Black DM, Nevitt MC, Browner WS, Cauley JA, Genant HK, Mascioli SR, Scott JC, Seeley DG, Steiger P et al (1990) Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA 263:665-668 (Pubitemid 20042530)
2. Melton LR, Chrischilles EA, Cooper C, Lane AW, Riggs BL (1992) How many women have osteoporosis? [Perspective]. J Bone Miner Res 7:1005-1010
3. Wang L, Banu J, McMahan CA, Kalu DN (2001) Male rodent model of age-related bone loss in men. Bone 29:141-148 (Pubitemid 32737189)
4. Li ML (1994) Progress in the study on Fructus ligustri lucidi. Zhongguo Zhong Yao Za Zhi 19:504-506
5. Zhang Y, Lai WP, Leung PC, Wu CF, Yao XS, Wong MS (2006) Effects of Fructus ligustri lucidi extract on bone turnover and calcium balance in ovariectomized rats. Biol Pharm Bull 29:291-296 (Pubitemid 43200899)
6. Zhang Y, Dong XL, Leung PC, Che CT, Wong MS (2008) Fructus ligustri lucidi extract improves calcium balance and modulates the calciotropic hormone level and vitamin D-dependent gene expression in aged ovariectomized rats. Menopause 15:558-565 (Pubitemid 351681639)
7. Zhang Y, Leung PC, Che CT, Chow HK, Wu CF, Wong MS (2008) Improvement of bone properties and enhancement of mineralization by ethanol extract of Fructus ligustri lucidi. Br J Nutr 99:494-502 (Pubitemid 351223417)
8. Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194:S3-S11
9. Pitkin RM (1985) Calcium metabolism in pregnancy and the perinatal period: a review. Am J Obstet Gynecol 151:99-109
10. Emkey RD, Emkey GR (2012) Calcium metabolism and correcting calcium deficiencies. Endocrinol Metab Clin N Am 41:527-556
11. Gennari C (2001) Calcium and vitamin D nutrition and bone disease of the elderly. Public Health Nutr 4:547-559
12. Wang Y, Zhu J, DeLuca H (2012) Where is the vitamin D receptor. Arch Biochem Biophys 523:123-133
13. Song Y, Peng X, Porta A, Takanaga H, Peng JB, Hediger MA, Fleet JC, Christakos S (2003) Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1,25 dihydroxyvitamin D3 in the intestine and kidney of mice. Endocrinology 144:3885-3894 (Pubitemid 37088743)
14. Bouillon R, Van Cromphaut S, Carmeliet G (2003) Intestinal calcium absorption: molecular vitamin D mediated mechanisms. J Cell Biochem 88:332-339 (Pubitemid 36119907)
15. Christakos S (2012) Recent advances in our understanding of 1,25-dihydroxyvitamin D(3) regulation of intestinal calcium absorption. Arch Biochem Biophys 523:73-76
16. Clark J, Gebhart G, Gonder J, Keeling M, Kohn D (1997) The 1996 guide for the care and use of laboratory animals. ILAR J 38:41-48
17. Radonic A, Thulke S, Mackay IM, Landt O, Siegert W, Nitsche A (2004) Guideline to reference gene selection for quantitative realtime PCR. Biochem Biophys Res Commun 313:856-862 (Pubitemid 38050071)
18. Wada S, Kamiya S (2006) Bone and bone related biochemical examinations. Bone and collagen related metabolites. Osteocalcin (OC). Clin Calcium 16:1017-1021
19. Neve A, Corrado A, Cantatore FP (2013) Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol 228:1149-1153
20. Chapurlat RD, Garnero P, Breart G, Meunier PJ, Delmas PD (2000) Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study. Bone 27:283-286 (Pubitemid 30458823)
21. Rosen HN, Moses AC, Garber J, Iloputaife ID, Ross DS, Lee SL, Greenspan SL (2000) Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int 66:100-103 (Pubitemid 30056702)
22. Fong L, Muhlhausler BS, Gibson RA, Xian CJ (2012) Perinatal maternal dietary supplementation of omega3-fatty acids transiently affects bone marrow microenvironment, osteoblast and osteoclast formation, and bone mass in male offspring. Endocrinology 153:2455-2465
23. Christakos S, Dhawan P, Porta A, Mady LJ, Seth T (2011) Vitamin D and intestinal calcium absorption. Mol Cell Endocrinol 347:25-29
24. Fleet JC, Schoch RD (2010) Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors. Crit Rev Clin Lab Sci 47:181-195
25. Miller WL, Portale AA (2000) Vitamin D 1 alpha-hydroxylase. Trends Endocrinol Metab 11:315-319
26. Bikle DD (2012) Vitamin D and bone. Curr Osteoporos Rep 10:151-159
27. 3 by inducing renal 25-hydroxyvitamin D-1alpha hydroxylase activity. Menopause 17:1174-1181
28. Wu S, Ren S, Nguyen L, Adams JS, Hewison M (2007) Splice variants of the CYP27b1 gene and the regulation of 1,25-dihydroxyvitamin D3 production. Endocrinology 148:3410-3418 (Pubitemid 46997000)
29. Shi L, Ma Y, Cai Z (1998) Quantitative determination of salidroside and specnuezhenide in the fruits of Ligustrum lucidum Ait. by high performance liquid chromatography. Biomed Chromatogr 12:27-30 (Pubitemid 28040914)
30. Lin HM, Yen FL, Ng LT, Lin CC (2007) Protective effects of Ligustrum lucidum fruit extract on acute butylated hydroxytoluene-induced oxidative stress in rats. J Ethnopharmacol 111:129-136 (Pubitemid 46482886)
31. Xia EQ, Yu YY, Xu XR, Deng GF, Guo YJ, Li HB (2012) Ultrasound-assisted extraction of oleanolic acid and ursolic acid from Ligustrum lucidum Ait. Ultrason Sonochem 19:772-776
32. Liu J (1995) Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 49:57-68
33. Lee SU, Park SJ, Kwak HB, Oh J, Min YK, Kim SH (2008) Anabolic activity of ursolic acid in bone: stimulating osteoblast differentiation in vitro and inducing new bone formation in vivo. Pharmacol Res 58:290-296
34. Li JX, Hareyama T, Tezuka Y, Zhang Y, Miyahara T, Kadota S (2005) Five new oleanolic acid glycosides from Achyranthes bidentata with inhibitory activity on osteoclast formation. Planta Med 71:673-679 (Pubitemid 41133079)
35. Sultana N (2011) Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product. J Enzyme Inhib Med Chem 26:616-642
36. Sultana N, Ata A (2008) Oleanolic acid and related derivatives as medicinally important compounds. J Enzym Inhib Med Chem 23:739-756
37. Murakami S, Takashima H, Sato-Watanabe M, Chonan S, Yamamoto K, Saitoh M, Saito S, Yoshimura H, Sugawara K, Yang J, Gao N, Zhang X (2004) Ursolic acid, an antagonist for transforming growth factor (TGF)-beta1. FEBS Lett 566:55-59 (Pubitemid 38625932)
38. Yoshimura H, Sugawara K, Saito M, Saito S, Murakami S, Miyata N, Kawashima A, Morimoto S, Gao N, Zhang X, Yang J (2003) In vitro TGF-beta1 antagonistic activity of ursolic and oleanolic acids isolated from Clerodendranthus spicatus. Planta Med 69:673-675 (Pubitemid 37041066)
39. Roberts AB (1998) Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24:111-119
40. Adams JS, Hewison M (2012) Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch Biochem Biophys 523:95-102
41. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429-435 (Pubitemid 38787398)
42. Quarles LD (2012) Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat Rev Endocrinol 8:276-286
43. Dangpei L (2010) Effects of FGF-23 overexpression on SOD and GSH2PX activity and MDA contents in mouse renal, hepatic and hippocampal tissues. J Southeast Univ (Med Sci Ed) 29:123-126